Literature DB >> 26895584

Management of the Formosa Color Dust Explosion: Lessons Learned from the Treatment of 49 Mass Burn Casualty Patients at Chang Gung Memorial Hospital.

Ming-Huei Cheng1,2, Alexandra L Mathews1,2, Shiow-Shuh Chuang1,2, Meghan E Lark1,2, Yen-Chang Hsiao1,2, Chip-Jin Ng1,2, Kevin C Chung1,2.   

Abstract

BACKGROUND: This article reports the emergency management of a mass casualty disaster occurring on June 27, 2015, in New Taipei, Taiwan, as a fire erupted over a large crowd, injuring 499 people. Lessons learned in burn care treatment and disaster preparedness are analyzed through following the specific surgical response and patient outcomes of one hospital involved in the disaster response.
METHODS: Information regarding the fire and emergency management was obtained from the Ministry of Health and Welfare of Taiwan. Patient-specific data were obtained from Chang Gung Memorial Hospital's patient records.
RESULTS: A mass casualty management system was immediately initiated by the Ministry of Health and Welfare, which contacted local hospitals to prepare for the influx of patients with severe burn injuries. In response, Chang Gung Memorial Hospital called 336 medical personnel to the emergency room for the management of 49 burn patients and divided emergency management roles among chief physicians. The mean burn total body surface area of patients presenting to this hospital was 44.2 percent (range, 10 to 90 percent). No deaths occurred in the first 48 hours after the explosion. As of 3 months after the incident, only 12 deaths had resulted from this accident, all resulting from sepsis and organ failure.
CONCLUSIONS: Taiwan's effective mass casualty preparation plans, highly trained medical personnel, and large centers capable of treating burn patients allowed 499 injured patients to be successfully transferred and treated in hospitals across Taiwan. Lessons learned from this disaster response can be integrated into existing disaster management plans to aid in the response to mass casualty tragedies. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895584     DOI: 10.1097/PRS.0000000000002148

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Cost Analysis of 48 Burn Patients in a Mass Casualty Explosion Treated at Chang Gung Memorial Hospital.

Authors:  Alexandra L Mathews; Ming-Huei Cheng; John-Michael Muller; Miffy Chia-Yu Lin; Kate W C Chang; Kevin C Chung
Journal:  Injury       Date:  2016-08-16       Impact factor: 2.586

2.  Review of Emergency Response Management of 33 Major Burn Victims of the Formosa Fun Coast Dust Explosion Disaster in a Regional Hospital Without Burn Units.

Authors:  Chieh-Hung Lin; Wei-Lun Chen; Bor-Hen Wu; Tzu-Yao Hung
Journal:  J Acute Med       Date:  2019-09-01

3.  The predisposing factors of AKI for prophylactic strategies in burn care.

Authors:  Shin-Yi Tsai; Chon-Fu Lio; Shou-Chuan Shih; Cheng-Jui Lin; Yu-Tien Chen; Chia-Meng Yu; Fang-Ju Sun; Chien-Feng Kuo; Xiaofeng Jia
Journal:  PeerJ       Date:  2020-09-29       Impact factor: 2.984

4.  Developing a Delphi-Based Comprehensive Core Set from the International Classification of Functioning, Disability, and Health Framework for the Rehabilitation of Patients with Burn Injuries.

Authors:  Yu-Ru Lin; Jr-Yi Wang; Shun-Cheng Chang; Kwang-Hwa Chang; Hung-Chou Chen; Reuben Escorpizo; Shih-Wei Huang; Tsan-Hon Liou
Journal:  Int J Environ Res Public Health       Date:  2021-04-09       Impact factor: 3.390

5.  Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship.

Authors:  Po-Yen Huang; Shian-Sen Shie; Jung-Jr Ye; Shih-Pin Lin; Tsui-Ping Liu; Ting-Shu Wu; Tsu-Lan Wu; Shiow-Shuh Chuang; Ming-Huei Cheng; Yu-Chia Hsieh; Ching-Tai Huang
Journal:  BMC Infect Dis       Date:  2017-08-30       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.